This training provides healthcare teams with information on the available extended-release injectable buprenorphine formulations for the treatment of opioid use disorder and how to implement them into clinical practice.
Topics include the pharmacology and side effects of extended-release injectable buprenorphine formulations; storage, administration, and patient selection processes; dosage, initiation, and maintenance for patients using weekly and monthly injectable doses; and the workflows and administrative tasks involved in implementing extended-release injectable buprenorphine in healthcare settings.
NOTE: This training is 60 minutes long. There will be an optional 30-minute Q&A session following the training, which will not count for credit.
